- Price
- $75.58
- Day
- +2.96%
- Mkt Cap
- $2.60B
- 52W Range
- $45.66 – $79.29
- Volume
- 185.2K
- Beta
- 1.17
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Bank of New York Mellon Corp reduced its stake in shares of Ingevity Corporation (NYSE: NGVT) by 6.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 211,002 shares of the company's stock after selling 13,808 shares during the quarter.
Read full article
Ingevity NYSE: NGVT reported second-quarter 2026 results marked by higher adjusted earnings, margin expansion and progress on its portfolio simplification efforts, as the company raised its full-year adjusted EBITDA and earnings-per-share outlook.
Read full article
Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Read full article
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year.
Read full article
Ingevity (NGVT) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.39 per share a year ago.
Read full article
Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.
Read full article
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Evotherm® P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt.
Read full article